Clinical Trials Logo
  1. Home
  2. Skin Scarring
  3. NCT03306628

Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden

Skin Scarring Clinical Trial

Official title:
Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden

Clinical Trial Summary

This is a prospective, randomized pilot study of patients who will undergo either early or late incisional laser therapy after breast reduction surgery to alleviate scar burden at NYU Langone Medical Center. The purpose of this study is to see how well carbon dioxide (CO2) laser therapy works at preventing scar formation after surgery.CO2 laser therapy is currently being used by dermatologists and plastic surgeons to help with scarring after acne and to rejuvenate the face; its benefits are now being explored by medical professionals in dermatology and cosmetic surgery to prevent scarring after surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03306628
Study type Interventional
Source NYU Langone Health
Contact
Status Withdrawn
Phase N/A
Start date November 15, 2017
Completion date August 26, 2019
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03649308 - Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting N/A
Completed NCT05618912 - Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment N/A
Completed NCT03795116 - Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention Phase 2
Active, not recruiting NCT01688063 - Skin Elasticity Measurements of the Face and Surgical Scars Stratified by Age and Skin Type
Recruiting NCT06465056 - Use of Botulinum Toxin A in Direct Eyebrow Lift Scar Phase 2
Completed NCT05704114 - Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne Phase 4
Active, not recruiting NCT04915391 - Restenosis in Coronary Stents And Cutaneous HEaLing